Ultragenyx Pharmaceutical Inc. trailing returns
Ultragenyx Pharmaceutical Inc.'s 10-year return is -13.4% a year (CAGR) (-76.4% cumulative). How Ultragenyx Pharmaceutical Inc. (RARE) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -4.2% | +0.0% | -4.2% | — |
| 5 days | -6.1% | +0.0% | -6.1% | -6.1%Oct 16 |
| 1 month | +12.9% | +0.0% | +12.9% | -7.7%Sep 28 |
| YTD | -36.8% | +0.0% | -36.8% | -64.1%Sep 16 |
| 1 year | -57.2% | +0.0% | -57.2% | -64.8%Sep 2026 |
| 5 years | -28.9% | +0.0% | -28.9%-81.8% | -85.3%Sep 2026 |
| 10 years | -13.4% | +0.0% | -13.4%-76.4% | -92.7%Sep 2026 |
| Since inception (2014) | -8.1% | +0.0% | -8.1%-65.6% | -92.7%Sep 2026 |
Growth of RARE#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-28.9%/year · -81.8%
- 10 years-13.4%/year · -76.4%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RARE's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Ultragenyx Pharmaceutical Inc.'s 10-year return?
- Over the last 10 years, Ultragenyx Pharmaceutical Inc. (RARE) returned about -13.4% a year annualized (-76.4% cumulative total return).
- What is Ultragenyx Pharmaceutical Inc.'s return since inception?
- Since 2014, Ultragenyx Pharmaceutical Inc. (RARE) has compounded at about -8.1% a year — -65.6% in total.